Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: A shotgun lipidomics study

Biochemistry

Volumn 46, Issue 21, 2007, Pages 6417-6428

  Han, Xianlin ^a   Yang, Jingyue ^a   Yang, Kui ^a   Zhongdan, Zhao ^a   Abendschein, Dana R ^a   Gross, Richard W ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN (CL); STREPTOZOTOCIN (STZ) INJECTION; TRIACYLGLYCEROL CONTENTS;

CELLS; DISEASES; GLYCEROL; HYDROLYSIS; PRECIPITATION (CHEMICAL);

PHOSPHOLIPIDS;

CARDIOLIPIN; LIPID; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CHEMICAL COMPOSITION; CONTROLLED STUDY; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEART MUSCLE; HYDROLYSIS; MALE; METABOLISM; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ANIMALS; CARDIOLIPINS; CARDIOMYOPATHIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS, UNSATURATED; LIPID METABOLISM; LIPIDS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; TANDEM MASS SPECTROMETRY;

MUS;

EID: 34249672811     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi7004015     Document Type: Article

References (44)

1. Lopaschuk, G. D., and Russell, J. C. (1991) Myocardial function and energy substrate metabolism in the insulin-resistant JCR:LA corpulent rat, J. Appl. Physiol. 71, 1302-1308.
2. Han, X., Abendschein, D. R., Kelley, J. G., and Gross, R. W. (2000) Diabetes-induced changes in specific lipid molecular species in rat myocardium, Biochem. J. 352, 79-89.
3. Zhou, Y. T., Shimabukuro, M., Lee, Y., Koyama, K., Higa, M., Ferguson, T., and Unger, R. H. (1998) Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes, Diabetes 47, 1904-1908.
4. Kraegen, E. W., Cooney, G. J., Ye, J. M., Thompson, A. L., and Furier, S. M. (2001) The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity, Exp. Clin. Endocrinol. Diabetes 109 (Suppl. 2), S189-S201.
5. Su, X., Han, X., Mancuso, D. J., Abendschein, D. R., and Gross, R. W. (2005) Accumulation of long-chain acylcarnitine and 3-hydroxy acylcarnitine molecular species in diabetic myocardium: identification of alterations in mitochondrial fatty acid processing in diabetic myocardium by shotgun lipidomics, Biochemistry 44, 5234-5245.
6. Han, X., Yang, J., Cheng, H., Yang, K., Abendschein, D. R., and Gross, R. W. (2005) Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction, Biochemistry 44, 16684-16694.
7. Unger, R. H. (2002) Lipotoxic diseases, Annu. Rev. Med. 53, 319-336.
8. Hung, T., Sievenpiper, J. L., Marchie, A., Kendall, C. W., and Jenkins, D. J. (2003) Fat versus carbohydrate in insulin resistance, obesity, diabetes and cardiovascular disease, Curr. Opin. Clin. Nutr. Metab. Care 6, 165-176.
9. Finck, B. N., Han, X., Courtois, M., Aimond, F., Nerbonne, J. M., Kovacs, A., Gross, R. W., and Kelly, D. P. (2003) A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content, Proc. Natl. Acad. Sci. U.S.A. 100, 1226-1231.
10. Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., and Kelly, D. P. (2002) The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus, J. Clin. Invest. 109, 121-130.
11. Kelley, D. E. (2002) Skeletal muscle triglycerides: an aspect of regional adiposity and insulin resistance, Ann. N.Y. Acad. Sci. 967, 135-145.
12. Schlame, M., and Haldar, D. (1993) Cardiolipin is synthesized on the matrix side of the inner membrane in rat liver mitochondria, J. Biol. Chem. 268, 74-79.
13. Mandieau, V., Martin, I., and Ruysschaert, J. M. (1995) Interaction between cardiolipin and the mitochondrial presequence of cytochrome c oxidase subunit IV favours lipid mixing without destabilizing the bilayer structure, FEBS Lett. 368, 15-18.
14. Zhang, M., Mileykovskaya, E., and Dowhan, W. (2002) Gluing the respiratory chain together. Cardiolipin is required for super-complex formation in the inner mitochondrial membrane, J. Biol. Chem. 277, 43553-43556.
15. Pfeiffer, K., Gohil, V., Stuart, R. A., Hunte, C., Brandt, U., Greenberg, M. L., and Schagger, H. (2003) Cardiolipin stabilizes respiratory chain supercomplexes, J. Biol. Chem. 278, 52873-52880.
16. Vreken, P., Valianpour, F., Nijtmans, L. G., Grivell, L. A., Plecko, B., Wanders, R. J., and Barth, P. G. (2000) Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome, Biochem. Biophys. Res. Commun. 279, 378-382.
17. Schlame, M., Towbin, J. A., Heerdt, P. M., Jehle, R., DiMauro, S., and Blanek, T. J. (2002) Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome, Ann. Neurol. 51, 634-637.
18. Valianpour, F., Wanders, R. J., Overmars, H., Vreken, P., Van Gennip, A. H., Baas, F., Plecko, B., Santer, R., Becker, K., and Barth, P. G. (2002) Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts, J. Pediatr. 141, 729-733.
19. Barth, P. G., Valianpour, F., Bowen, V. M., Lam, J., Duran, M., Vaz, F. M., and Wanders, R. J. (2004) X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update, Am. J. Med. Genet. A 126, 349-354.
20. Gu, Z., Valianpour, F., Chen, S., Vaz, F. M., Hakkaart, G. A., Wanders, R. J., and Greenberg, M. L. (2004) Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome, Mol. Microbiol. 51, 149-158.
21. Hauff, K. D., and Hatch, G. M. (2006) Cardiolipin metabolism and Barth Syndrome, Prog. Lipid Res. 45, 91-101.
22. Li, G., Chen, S., Thompson, M. N., and Greenberg, M. L. (2006) New insights into the regulation of cardiolipin biosynthesis in yeast: Implications for Barth syndrome, Biochim. Biophys. Acta (doi:10.1016/j.bbalip.2006. 1006.1007).
23. Schlame, M., and Ren, M. (2006) Barth syndrome, a human disorder of cardiolipin metabolism, FEBS Lett. 580, 5450-5455.
24. Xu, Y., Kelley, R. I., Blanek, T. J., and Schlame, M. (2003) Remodeling of cardiolipin by phospholipid transacylation, J. Biol. Chem. 278, 51380-51385.
25. Vaz, F. M., Houtkooper, R. H., Valianpour, F., Barth, P. G., and Wanders, R. J. (2003) Only one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabolism, J. Biol. Chem. 278, 43089-43094.
26. Han, X., and Gross, R. W. (2003) Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics, J. Lipid Res. 44, 1071-1079.
27. Han, X., Yang, J., Cheng, H., Ye, H., and Gross, R. W. (2004) Towards fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry, Anal. Biochem. 330, 317-331.
28. Han, X., and Gross, R. W. (2005) Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of the cellular lipidomes directly from crude extracts of biological samples, Mass Spectrom. Rev. 24, 367-412.
29. Han, X., and Gross, R. W. (2005) Shotgun lipidomics: multidimensional mass spectrometric analysis of cellular lipidomes, Expert Rev. Proteomics 2, 253-264.
30. Han, X., Yang, K., Yang, J., Cheng, H., and Gross, R. W. (2006) Shotgun lipidomics of cardiolipin molecular species in lipid extracts of biological samples, J. Lipid Res. 47, 864-879.
31. Gross, R. W. (1984) High plasmalogen and arachidonic acid content of canine myocardial sarcolemma: a fast atom bombardment mass spectroscopic and gas chromatography-mass spectroscopic characterization, Biochemistry 23, 158-165.
32. Bligh, E. G., and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification, Can. J. Biochem. Physiol. 37, 911-917.
33. Golovko, M. Y., and Murphy, E. J. (2004) An improved method for tissue long-chain acyl-CoA extraction and analysis, J. Lipid Res. 45, 1777-1782.
34. Kalderon, B., Sheena, V., Shachrur, S., Hertz, R., and Bar-Tana, J. (2002) Modulation by nutrients and drugs of liver acyl-CoAs analyzed by mass spectrometry, J. Lipid Res. 43, 1125-1132.
35. Herberg, L., and Coleman, D. L. (1977) Laboratory animals exhibiting obesity and diabetes syndromes, Metabolism 26, 59-99.
36. Bray, G. A., and York, D. A. (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis, Physiol. Rev. 59, 719-809.
37. Han, X., and Gross, R. W. (2001) Quantitative analysis and molecular species fingerprinting of triacylglyceride molecular species directly from lipid extracts of biological samples by electrospray ionization tandem mass spectrometry, Anal. Biochem. 295, 88-100.
38. Han, X., Cheng, H., Mancuso, D. J., and Gross, R. W. (2004) Caloric restriction results in phospholipid depletion, membrane remodeling and triacylglycerol accumulation in murine myocardium, Biochemistry 43, 15584-15594.
39. Xu, Y., Malhotra, A., Ren, M., and Schlame, M. (2006) The enzymatic function of tafazzin, J. Biol. Chem. (in press).
40. Schlame, M., Rua, D., and Greenberg, M. L. (2000) The biosynthesis and functional role of cardiolipin, Prog. Lipid Res. 39, 257-288.
41. Iverson, S. L., and Orrenius, S. (2004) The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis, Arch. Biochem. Biophys. 423, 37-46.
42. Hatch, G. M. (2004) Cell biology of cardiac mitochondrial phospholipids, Biochem. Cell Biol. 82, 99-112.
43. McMillin, J. B., and Dowhan, W. (2002) Cardiolipin and apoptosis, Biochim. Biophys. Acta 1585, 97-107.
44. Chicco, A. J., and Sparagna, G. C. (2007) Role of cardiolipin alterations in mitochondrial dysfunction and disease, Am. J. Physiol. Cell. Physiol. 292, C33-C44.